Diagnostic utility of ESR1 mutation detection in liquid biopsy of metastatic breast cancer patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Diagnostic utility of ESR1 mutation detection in liquid biopsy of metastatic breast cancer patients ; day:11 ; month:10 ; year:2024 ; pages:1-5
Virchows Archiv ; (11.10.2024), 1-5
- Creator
-
Sandbothe, Maria
Hasemeier, Britta
Schipper, Elisa
Schaumann, Nora
Kreipe, Hans
Lehmann, Ulrich
Bartels, Stephan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00428-024-03942-1
- URN
-
urn:nbn:de:101:1-2412302107025.088383105781
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sandbothe, Maria
- Hasemeier, Britta
- Schipper, Elisa
- Schaumann, Nora
- Kreipe, Hans
- Lehmann, Ulrich
- Bartels, Stephan
- SpringerLink (Online service)
Other Objects (12)
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
ESR1 Liquid Biopsy im metastasierten Mammakarzinom bei endokriner Resistenz
ESR1 mutations in metastatic lobular breast cancer patients
Utility of computed tomography-guided biopsy in evaluation of metastatic spinal lesions
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer
Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell lines
ESR1-Amplifikationen in humanen gynäkologischen Tumoren
Identification of a novel ESR1 mutation in a Chinese PCOS woman with estrogen insensitivity in IVF treatment
Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
ESR1 Liquid Biopsy im metastasierten Mammakarzinom bei endokriner Resistenz
ESR1 mutations in metastatic lobular breast cancer patients
Utility of computed tomography-guided biopsy in evaluation of metastatic spinal lesions
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer
Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell lines
ESR1-Amplifikationen in humanen gynäkologischen Tumoren
Identification of a novel ESR1 mutation in a Chinese PCOS woman with estrogen insensitivity in IVF treatment
Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
ESR1 Liquid Biopsy im metastasierten Mammakarzinom bei endokriner Resistenz
ESR1 mutations in metastatic lobular breast cancer patients
Utility of computed tomography-guided biopsy in evaluation of metastatic spinal lesions
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer
Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell lines
ESR1-Amplifikationen in humanen gynäkologischen Tumoren
Identification of a novel ESR1 mutation in a Chinese PCOS woman with estrogen insensitivity in IVF treatment